Skip to content

Effect of Buteyko Breathing Retraining on Respiratory Indices, activity and anxiety level, in Patients with Anxiety Disorder - A Randomized controlled Trial

Effect of Buteyko Breathing Retraining on Respiratory Indices, activity and anxiety level, in Patients with Anxiety Disorder - A Randomized controlled Trial

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20181017041374N1
Enrollment
30
Registered
2020-01-27
Start date
2019-06-21
Completion date
Unknown
Last updated
2020-02-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with General Anxiety disorder. Generalized anxiety disorder

Interventions

Intervention 1: Intervention group: Individuals with anxiety disorder are treated under the medication and routine counseling, which is referred to as intervention group by training exercises based on

Sponsors

Ahvaz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: Patients with anxiety disorder diagnosed by a physician Not having any illness or musculoskeletal-musculoskeletal system interfering with breathing and based on the examination and evaluation that the investigator will examine. Not having addiction to any drugs or cigarettes and alcohol Have a high school diploma degree The company does not have to do any physical or sporting activities professionally and earn points from the Beck Action Level Questionnaire. No breathing exercises have been performed, such as Buteyko exercises or other exercises Individuals with respiratory pattern of hyperventilation, who were evaluated by a semiann questionnaire score 23 to 64 to enter the study.

Exclusion criteria

Exclusion criteria: In case of unwillingness and tolerance of treatment intervention Pulse of heart over normal range based on age The presence of any problems with the upper airways, including polyps, and the deviation of the nasal blades that lead to breathing through the mouth and preventing breathing. This criterion is made through the rapid and common tests in the auditory services of the ENT and by the research team. Any dizziness and headache or nausea during or after exercise Excessive concern during the implementation of the project in such a way that the process of conducting research is compromised Cardiovascular disease based on self-expression Mentally retarded patients Pregnant

Design outcomes

Primary

MeasureTime frame
GAD-7 and Beck Anxiety Q?uestionnaire Scores. Timepoint: At the beginning of the intervention, during the study, approximately 4 weeks later, and at the end of the study, 8 weeks later. Method of measurement: Beck and GAD-7 Anxiety Inventory and Nigmegen Respiratory Function Questionnaire.

Secondary

MeasureTime frame
Forced Expiratory Volume in First second. Timepoint: Baseline and one month and two months later. Method of measurement: spirometry.;Forced Vital Capacity. Timepoint: Baseline and one month and two months later. Method of measurement: spirometry.;Ratio between Forced Expiratory Volume in First second/Forced Vital Capacity. Timepoint: Baseline and one month and two months later. Method of measurement: spirometry.;End tidal volume Expiratory carbon dioxide pressure. Timepoint: Baseline and one month and two months later. Method of measurement: Capnometry.;Heart Rate. Timepoint: Baseline and one month and two months later. Method of measurement: Capnometry.;Respiratory Rate. Timepoint: Baseline and one month and two months later. Method of measurement: Capnometry.;Respiratory function questionnaire score - Nijmegen. Timepoint: Baseline and one month and two months later. Method of measurement: Nijmegen questionnaire.;Beck Anxiety Inventory. Timepoint: Baseline and one month and two months later. Method of measurement: Beck Anxiety Inventory.;General Anxiety Disorder Questionnaire score. Timepoint: Baseline and one month and two months later. Method of measurement: General Anxiety Disorder Questionnaire GAD-7.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAlireza Maleki

Ahvaz University of Medical Sciences

maleki.a@ajums.ac.ir+98 61 3374 3101

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026